☰

Arta M. Monjazeb, Ph.D. - Publications

Affiliations: 
2003 Wake Forest University School of Medicine, Winston-Salem, NC, United States 
Area:
Molecular Biology, Cell Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

64 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Chen H, Shi L, Nguyen KNB, Monjazeb AM, Matsukuma KE, Loehfelm TW, Huang H, Qiu J, Rong Y. MRI Radiomics for Prediction of Tumor Response and Downstaging in Rectal Cancer Patients after Preoperative Chemoradiation. Advances in Radiation Oncology. 5: 1286-1295. PMID 33305090 DOI: 10.1016/J.Adro.2020.04.016  0.303
2020 Candas-Green D, Xie B, Huang J, Fan M, Wang A, Menaa C, Zhang Y, Zhang L, Jing D, Azghadi S, Zhou W, Liu L, Jiang N, Li T, Gao T, ... ... Monjazeb AM, et al. Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells. Nature Communications. 11: 4591. PMID 32929084 DOI: 10.1038/S41467-020-18245-7  0.385
2020 Demisse R, Damle N, Kim E, Gong J, Fakih M, Eng C, Oesterich L, McKenny M, Ji J, Liu J, Louie R, Tam K, Gholami S, Halabi W, Monjazeb A, et al. Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case Series. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 798-804. PMID 32634770 DOI: 10.6004/Jnccn.2020.7558  0.36
2020 Monjazeb AM, Schalper KA, Villarroel-Espindola F, Nguyen A, Shiao SL, Young K. Effects of Radiation on the Tumor Microenvironment. Seminars in Radiation Oncology. 30: 145-157. PMID 32381294 DOI: 10.1016/J.Semradonc.2019.12.004  0.344
2020 Judge SJ, Dunai C, Aguilar EG, Vick SC, Sturgill IR, Khuat LT, Stoffel KM, Van Dyke J, Longo DL, Darrow MA, Anderson SK, Blazar BR, Monjazeb AM, Serody JS, Canter RJ, et al. Minimal PD-1 expression in mouse and human NK cells under diverse conditions. The Journal of Clinical Investigation. PMID 32134744 DOI: 10.1172/Jci133353  0.301
2020 Judge SJ, Yanagisawa M, Sturgill IR, Bateni SB, Gingrich AA, Foltz JA, Lee DA, Modiano JF, Monjazeb AM, Culp WTN, Rebhun RB, Murphy WJ, Kent MS, Canter RJ. Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer. Plos One. 15: e0224775. PMID 32084139 DOI: 10.1371/Journal.Pone.0224775  0.385
2020 Chen J, Huynh J, Monjazeb A, Cho MT, Kim EJ. A pilot study of intratumoral SD-101 (toll-like receptor 9 agonist), nivolumab, and radiotherapy for treatment of chemotherapy-refractory metastatic pancreatic adenocarcinoma. Journal of Clinical Oncology. 38: TPS782-TPS782. DOI: 10.1200/Jco.2020.38.4_Suppl.Tps782  0.351
2020 Kelly K, Daly ME, Mirhadi A, Lara F, Garcia LA, Chen S, Eastham D, Wiegner EA, Riess JW, Schalper KA, Monjazeb A. Atezolizumab plus stereotactic ablative therapy for medically inoperable patients with early-stage non-small cell lung cancer. Journal of Clinical Oncology. 38: 9011-9011. DOI: 10.1200/Jco.2020.38.15_Suppl.9011  0.315
2019 Chen H, Bao Nguyen KN, Huang H, Feng C, Zhao X, Daly ME, Rao S, Fragoso R, Valicenti R, Sekhon S, Navarro SM, Kim EJ, Cho M, Tam K, Farkas L, ... ... Monjazeb AM, et al. Impact and safety of radiotherapy boost to extra-mesorectal lymph nodes in rectal cancer. Practical Radiation Oncology. PMID 31866577 DOI: 10.1016/J.Prro.2019.12.007  0.309
2019 Naik A, Monjazeb AM, Decock J. The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer. Frontiers in Immunology. 10: 1940. PMID 31475003 DOI: 10.3389/Fimmu.2019.01940  0.371
2019 Dyer BA, Li CS, Daly ME, Monjazeb AM, Mayadev JS. Prospective, randomized control trial investigating the impact of a physician communicated radiotherapy plan review on breast cancer patient-reported satisfaction. Practical Radiation Oncology. PMID 31226443 DOI: 10.1016/J.Ijrobp.2017.06.106  0.309
2019 Saiz AM, Gingrich AA, Canter RJ, Kirane AR, Monjazeb AM, Randall RL, Thorpe SW. Role of Radiation Therapy in Adult Extraskeletal Ewing's Sarcoma Patients Treated with Chemotherapy and Surgery. Sarcoma. 2019: 5413527. PMID 31178655 DOI: 10.1155/2019/5413527  0.312
2019 George TJ, Franke AJ, Chakravarthy AB, Das P, Dasari A, El-Rayes BF, Hong TS, Kinsella TJ, Landry JC, Lee JJ, Monjazeb AM, Jacobs SA, Raben D, Rahma OE, Williams TM, et al. National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer. Cancer. PMID 31017664 DOI: 10.1002/Cncr.32150  0.369
2019 Withers SS, York D, Choi JW, Woolard KD, Laufer-Amorim R, Sparger EE, Burton JH, McSorley SJ, Monjazeb AM, Murphy WJ, Canter RJ, Rebhun RB. Metastatic Immune Infiltrates Correlate with Those of the Primary Tumor in Canine Osteosarcoma. Veterinary and Comparative Oncology. PMID 30684301 DOI: 10.1111/Vco.12459  0.3
2019 Monjazeb A, Giobbie-Hurder A, Lako A, Tesfaye AA, Stroiney A, Gentzler RD, Jabbour S, Alese OB, Rahma OE, Cleary JM, Sharon E, Raben D, Mamon HJ, Streicher H, Chen HX, et al. Analysis of colorectal cancer patients treated on ETCTN 10021: A multicenter randomized trial of combined PD-L1 and CTLA-4 inhibition with targeted low-dose or hypofractionated radiation. Journal of Clinical Oncology. 37: 49-49. DOI: 10.1200/Jco.2019.37.8_Suppl.49  0.333
2019 Daly M, Monjazeb A, Mirhadi A, Eastham D, Lara F, Riess J, Wiegner E, Kelly K. MA02.07 A Phase I Trial of an Immune Checkpoint Inhibitor Plus Stereotactic Ablative Radiotherapy in Patients with Early Stage Non-Small Cell Lung Cancer Journal of Thoracic Oncology. 14: S254. DOI: 10.1016/J.Jtho.2019.08.507  0.338
2019 Azgahdi S, Candas D, Xie B, Zhang L, Zhang Y, Fan M, Liu L, Sweeney C, Pan C, Ozpiskin O, Vaughan A, Wang J, Xia S, Monjazeb A, Woloschak G, et al. Dual Blockade of CD47 and HER2 Re-sensitizes Resistant Breast Cancer Cells to Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 105: E39. DOI: 10.1016/J.Ijrobp.2019.06.705  0.355
2018 Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM, Sturgill IR, Grossenbacher SK, Withers SS, Rebhun RB, Hartigan-O'Connor DJ, Méndez-Lagares G, ... ... Monjazeb AM, et al. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nature Medicine. PMID 30420753 DOI: 10.1038/S41591-018-0221-5  0.328
2018 Withers SS, Skorupski KA, York D, Choi JW, Woolard KD, Laufer-Amorim R, Sparger EE, Rodriguez CO, McSorley SJ, Monjazeb AM, Murphy WJ, Canter RJ, Rebhun RB. Association of Macrophage and Lymphocyte Infiltration with Outcome in Canine Osteosarcoma. Veterinary and Comparative Oncology. PMID 30156029 DOI: 10.1111/Vco.12444  0.31
2018 Chavez M, Silvestrini MT, Ingham ES, Fite BZ, Mahakian LM, Tam SM, Ilovitsh A, Monjazeb AM, Murphy WJ, Hubbard NE, Davis RR, Tepper CG, Borowsky AD, Ferrara KW. Distinct immune signatures in directly treated and distant tumors result from TLR adjuvants and focal ablation. Theranostics. 8: 3611-3628. PMID 30026870 DOI: 10.7150/Thno.25613  0.35
2018 Henderson T, Chen M, Darrow MA, Li CS, Chiu CL, Monjazeb AM, Murphy WJ, Canter RJ. Alterations in cancer stem-cell marker CD44 expression predict oncologic outcome in soft-tissue sarcomas. The Journal of Surgical Research. 223: 207-214. PMID 29433875 DOI: 10.1016/J.Jss.2017.11.016  0.362
2018 Marciscano AE, Walker JM, McGee HM, Kim MM, Kunos CA, Monjazeb AM, Shiao SL, Tran PT, Ahmed MM. Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop. Journal For Immunotherapy of Cancer. 6: 6. PMID 29375032 DOI: 10.1186/S40425-018-0317-Y  0.382
2018 McGee H, Anastos H, Galsky M, Sfakianos J, Daly M, Monjazeb A, Stock R, Buckstein M, Mulholland D. Characterization of the Immune Exhaustion Phenotype in Murine Bladder Cancer Following Radiation International Journal of Radiation Oncology*Biology*Physics. 102: S154-S155. DOI: 10.1016/J.Ijrobp.2018.06.373  0.346
2017 Canter RJ, Grossenbacher SK, Foltz JA, Sturgill IR, Park JS, Luna JI, Kent MS, Culp WTN, Chen M, Modiano JF, Monjazeb AM, Lee DA, Murphy WJ. Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial. Journal For Immunotherapy of Cancer. 5: 98. PMID 29254507 DOI: 10.1186/S40425-017-0305-7  0.311
2017 Baird JR, Monjazeb AM, Shah O, McGee H, Murphy WJ, Crittenden MR, Gough MJ. Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control. International Journal of Radiation Oncology, Biology, Physics. 99: 362-373. PMID 28871985 DOI: 10.1016/J.Ijrobp.2017.04.014  0.357
2017 Day D, Monjazeb AM, Sharon E, Ivy SP, Rubin EH, Rosner GL, Butler MO. From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 23: 4980-4991. PMID 28864726 DOI: 10.1158/1078-0432.Ccr-16-3064  0.34
2017 Mehnert JM, Monjazeb AM, Beerthuijzen JMT, Collyar D, Rubinstein L, Harris LN. The Challenge for Development of Valuable Immuno-oncology Biomarkers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 23: 4970-4979. PMID 28864725 DOI: 10.1158/1078-0432.Ccr-16-3063  0.341
2017 Sckisel GD, Mirsoian A, Minnar CM, Crittenden M, Curti B, Chen JQ, Blazar BR, Borowsky AD, Monjazeb AM, Murphy WJ. Differential phenotypes of memory CD4 and CD8 T cells in the spleen and peripheral tissues following immunostimulatory therapy. Journal For Immunotherapy of Cancer. 5: 33. PMID 28428882 DOI: 10.1186/S40425-017-0235-4  0.316
2017 Silvestrini MT, Ingham ES, Mahakian LM, Kheirolomoom A, Liu Y, Fite BZ, Tam SM, Tucci ST, Watson KD, Wong AW, Monjazeb AM, Hubbard NE, Murphy WJ, Borowsky AD, Ferrara KW. Priming is key to effective incorporation of image-guided thermal ablation into immunotherapy protocols. Jci Insight. 2: e90521. PMID 28352658 DOI: 10.1172/Jci.Insight.90521  0.365
2017 Candas D, Zhang L, Menaa C, Fan M, Zhang Y, Liu L, Zhou W, Azghadi S, Sweeney C, Shen R, Lin T, Pan C, Vaughan AT, Wang JM, Chen H, ... ... Monjazeb AM, et al. Abstract LB-226: Dual inhibition of CD47 and HER2 to radiosensitize breast cancer cells Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-226  0.392
2017 Silvestrini MT, Ingham ES, Mahakian LM, Kheirolomoom A, Liu Y, Fite BZ, Tam SM, Tucci S, Watson KD, Wong AW, Monjazeb AM, Hubbard NE, Murphy WJ, Borowsky AD, Ferrara KW. Abstract 576: Neoadjuvant immunotherapy improves efficacy of image-guided thermal ablation to generate curative responses in a murine breast cancer model Cancer Research. 77: 576-576. DOI: 10.1158/1538-7445.Am2017-576  0.351
2016 Park JS, Withers SS, Modiano JF, Kent MS, Chen M, Luna JI, Culp WT, Sparger EE, Rebhun RB, Monjazeb AM, Murphy WJ, Canter RJ. Canine cancer immunotherapy studies: linking mouse and human. Journal For Immunotherapy of Cancer. 4: 97. PMID 28031824 DOI: 10.1186/S40425-016-0200-7  0.372
2016 Azghadi S, Candas D, Monjazeb AM, Fan M, Mayadev JS, Li JJ. CD47 as a Target for Immune-Radiation Therapy for HER2-Expressing Breast Cancer Cells. International Journal of Radiation Oncology, Biology, Physics. 96: S147. PMID 27675640 DOI: 10.1016/J.Ijrobp.2016.06.356  0.372
2016 Monjazeb AM, Kent MS, Grossenbacher SK, Mall C, Zamora AE, Mirsoian A, Chen M, Kol A, Shiao SL, Reddy A, Perks JR, Culp W, Sparger EE, Canter RJ, Sckisel GD, et al. Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Anti-tumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26979392 DOI: 10.1158/1078-0432.Ccr-15-3026  0.374
2016 Ager C, Reilley M, Nicholas C, Bartkowiak T, Jaiswal A, Curran M, Albershardt TC, Bajaj A, Archer JF, Reeves RS, Ngo LY, Berglund P, ter Meulen J, Denis C, Ghadially H, ... ... Monjazeb A, et al. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Journal For Immunotherapy of Cancer. 4. DOI: 10.1186/S40425-016-0173-6  0.305
2015 Daly ME, Monjazeb AM, Kelly K. Clinical Trials Integrating Immunotherapy and Radiation for Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 26484629 DOI: 10.1097/Jto.0000000000000686  0.379
2015 Ames E, Canter RJ, Grossenbacher SK, Mac S, Smith RC, Monjazeb AM, Chen M, Murphy WJ. Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells. Oncoimmunology. 4: e1036212. PMID 26405602 DOI: 10.1080/2162402X.2015.1036212  0.352
2015 Ames E, Canter RJ, Grossenbacher SK, Mac S, Chen M, Smith RC, Hagino T, Perez-Cunningham J, Sckisel GD, Urayama S, Monjazeb AM, Fragoso RC, Sayers TJ, Murphy WJ. NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype. Journal of Immunology (Baltimore, Md. : 1950). 195: 4010-9. PMID 26363055 DOI: 10.4049/Jimmunol.1500447  0.407
2015 Sckisel GD, Bouchlaka MN, Monjazeb AM, Crittenden M, Curti BD, Wilkins DE, Alderson KA, Sungur CM, Ames E, Mirsoian A, Reddy A, Alexander W, Soulika A, Blazar BR, Longo DL, et al. Out-of-Sequence Signal 3 Paralyzes Primary CD4(+) T-Cell-Dependent Immunity. Immunity. 43: 240-50. PMID 26231116 DOI: 10.1016/J.Immuni.2015.06.023  0.317
2015 Canter R, Grossenbacher S, Park J, Modiano J, Miller J, Ames E, Mac S, Monjazeb A, Kent M, Culp W, Chen M, Murphy W. Combination radioimmunotherapy with adoptive NK transfer to target cancer stem cells in canine models of sarcoma F1000research. 4. DOI: 10.7490/F1000Research.1111170.1  0.327
2015 Canter R, Grossenbacher SK, Park JS, Modiano J, Ames E, Mac S, Monjazeb AM, Kent M, Culp W, Chen M, Murphy W. Combination radioimmunotherapy with adoptive NK transfer targets cancer stem cells in canine models of bone and soft tissue sarcoma Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P4  0.339
2015 Monjazeb AM, Kent M, Grossenbacher SK, Murphy W. Blocking indolamine 2,3 dioxygenase mediated rebound immune suppression improves systemic anti-tumor effects of radio-immunotherapy Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P368  0.353
2014 Wong P, Houghton P, Kirsch DG, Finkelstein SE, Monjazeb AM, Xu-Welliver M, Dicker AP, Ahmed M, Vikram B, Teicher BA, Coleman CN, Machtay M, Curran WJ, Wang D. Combining targeted agents with modern radiotherapy in soft tissue sarcomas. Journal of the National Cancer Institute. 106. PMID 25326640 DOI: 10.1093/Jnci/Dju329  0.378
2014 Canter RJ, Ames E, Mac S, Grossenbacher SK, Chen M, Li CS, Borys D, Smith RC, Tellez J, Sayers TJ, Monjazeb AM, Murphy WJ. Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma. Bmc Cancer. 14: 756. PMID 25301268 DOI: 10.1186/1471-2407-14-756  0.341
2014 Kao CJ, Wurz GT, Monjazeb AM, Vang DP, Cadman TB, Griffey SM, Wolf M, DeGregorio MW. Antitumor effects of cisplatin combined with tecemotide immunotherapy in a human MUC1 transgenic lung cancer mouse model. Cancer Immunology Research. 2: 581-9. PMID 24894093 DOI: 10.1158/2326-6066.Cir-13-0205  0.332
2014 Mall C, Sckisel GD, Mirsoian A, Pai CS, Grossenbacher S, Proia D, Chen M, Monjazeb A, Blazar BR, Murphy WJ. Monoclonal antibody therapies targeting immune checkpoints induce fatal anaphylactic reactions in a murine model of breast cancer F1000research. 5. DOI: 10.7490/F1000Research.1097400.1  0.325
2014 Grossenbacher SK, Ames E, Mac S, Masoud R, Canter RJ, Monjazeb AM, Murphy WJ. Enhanced natural killer cell targeting of cancer stem cells using Cetuximab Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-P13  0.392
2014 Mirsoian A, Bouchlaka MN, Sckisel G, Chen M, Pai CS, Maverakis E, Spencer R, Fishbein K, Siddiqui S, Monjazeb A, Martin B, Maudsley S, Hesdorffer C, Ferrucci L, Longo DL, et al. Adiposity As a Principal Component of Lethal Cytokine Storm Following Cancer Immunotherapy in Aged Mice Blood. 124: 460-460. DOI: 10.1182/Blood.V124.21.460.460  0.3
2014 Canter RJ, Ames E, Mac S, Grossenbacher SK, Chen M, Tellez J, Monjazeb AM, Murphy WJ. Abstract 1929: Tyrosine kinase inhibition with sorafenib but not pazopanib enriches for sarcoma cancer stem cells in diverse models of soft tissue sarcoma Cancer Research. 74: 1929-1929. DOI: 10.1158/1538-7445.Am2014-1929  0.391
2014 Canter R, Ames E, Mac S, Grossenbacher S, Smith R, Tellez J, Monjazeb A, Chen M, Murphy W. Sorafenib Enriches for Cancer Stem Cells in Pre-Clinical Models of Soft Tissue Sarcoma Journal of Surgical Research. 186: 682. DOI: 10.1016/J.Jss.2013.11.937  0.324
2014 Monjazeb A, Ames E, Murphy W, Canter R. Radiation Enhances Innate Immune Recognition of Cancer Stem Cells in Solid Tumors International Journal of Radiation Oncology*Biology*Physics. 90: S808. DOI: 10.1016/J.Ijrobp.2014.05.2331  0.352
2014 Monjazeb A, Ames E, Murphy W, Canter R. Radiation-Induced Changes in Chemokine Expression Promote Natural Killer Cell Homing International Journal of Radiation Oncology*Biology*Physics. 90: S775. DOI: 10.1016/J.Ijrobp.2014.05.2243  0.319
2013 Monjazeb AM, Zamora AE, Grossenbacher SK, Mirsoian A, Sckisel GD, Murphy WJ. Immunoediting and antigen loss: overcoming the achilles heel of immunotherapy with antigen non-specific therapies. Frontiers in Oncology. 3: 197. PMID 23898464 DOI: 10.3389/Fonc.2013.00197  0.334
2012 Bouchlaka MN, Sckisel GD, Wilkins D, Maverakis E, Monjazeb AM, Fung M, Welniak L, Redelman D, Fuchs A, Evrensel CA, Murphy WJ. Mechanical disruption of tumors by iron particles and magnetic field application results in increased anti-tumor immune responses. Plos One. 7: e48049. PMID 23133545 DOI: 10.1371/Journal.Pone.0048049  0.321
2012 Monjazeb AM, Hsiao HH, Sckisel GD, Murphy WJ. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer. Journal of Immunotoxicology. 9: 248-58. PMID 22734880 DOI: 10.3109/1547691X.2012.685527  0.346
2012 Kimple RJ, Russo S, Monjazeb A, Blackstock AW. The role of chemoradiation for patients with resectable or potentially resectable pancreatic cancer. Expert Review of Anticancer Therapy. 12: 469-80. PMID 22500684 DOI: 10.1586/Era.12.18  0.315
2012 Monjazeb A, Cui J, Daly M, Chen A, Fragoso R, Perks J, Mayadev J, Michaud A. A Retrospective Analysis of Setup Reproducibility for Anorectal Cancer Patients Treated Prone on a Belly Board International Journal of Radiation Oncology*Biology*Physics. 84: S745. DOI: 10.1016/J.Ijrobp.2012.07.1993  0.35
2010 Sanders AM, Stehle JR, Blanks MJ, Riedlinger G, Kim-Shapiro JW, Monjazeb AM, Adams JM, Willingham MC, Cui Z. Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirements. Bmc Cancer. 10: 121. PMID 20356394 DOI: 10.1186/1471-2407-10-121  0.345
2010 Monjazeb A, Riedlinger G, Isom S, Aklilu M, Geisinger K, Mishra G, Levine E, Blackstock A. Radiotherapy for Esophageal Cancer: Does Dose Affect Outcomes? International Journal of Radiation Oncology*Biology*Physics. 78: S307. DOI: 10.1016/J.Ijrobp.2010.07.729  0.318
2007 Kim C, Farmer M, Yacoub J, Monjazeb A, Levine E, Aklilu M, Geinsinger K, Mishra G, Melin S, Blackstock A. Tri-Modality Therapy for Esophageal Cancer: Mucinous Histology Is Associated With Decreased Pathologic Response Rates to Neoadjuvant Chemoradiation Therapy International Journal of Radiation Oncology*Biology*Physics. 69: S267. DOI: 10.1016/J.Ijrobp.2007.07.1287  0.317
2006 Monjazeb AM, High KP, Connoy A, Hart LS, Koumenis C, Chilton FH. Arachidonic acid-induced gene expression in colon cancer cells. Carcinogenesis. 27: 1950-60. PMID 16704987 DOI: 10.1093/Carcin/Bgl023  0.674
2005 Monjazeb AM, High KP, Koumenis C, Chilton FH. Inhibitors of arachidonic acid metabolism act synergistically to signal apoptosis in neoplastic cells. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 73: 463-74. PMID 16169197 DOI: 10.1016/J.Plefa.2005.07.009  0.634
2002 Clay CE, Monjazeb A, Thorburn J, Chilton FH, High KP. 15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells. Journal of Lipid Research. 43: 1818-28. PMID 12401880 DOI: 10.1194/Jlr.M200224-Jlr200  0.722
2002 Monjazeb AM, Clay CE, High KP, Chilton FH. Antineoplastic properties of arachidonic acid and its metabolites. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 66: 5-12. PMID 12051952 DOI: 10.1054/Plef.2001.0334  0.677
Show low-probability matches.